United States

Sequenom Inc (SQNM.OQ)

SQNM.OQ on NASDAQ Stock Exchange Global Select Market

22 Jul 2016
Change (% chg)

$-0.01 (-0.90%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for SQNM.OQ


Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North... (more)


Beta: 0.63
Market Cap(Mil.): $102.64
Shares Outstanding(Mil.): 119.22
Dividend: --
Yield (%): --


  SQNM.OQ Industry Sector
P/E (TTM): -- 32.64 37.05
EPS (TTM): -0.37 -- --
ROI: -42.91 8.45 14.35
ROE: -- 12.74 15.56

UPDATE 2-U.S. Supreme Court refuses to review prenatal test patent dispute

NEW YORK, June 27 The U.S. Supreme Court on Monday rejected a bid to review a legal fight over the cancellation of a patent on a less-risky form of prenatal testing, in a case that has left many companies and trade groups worried that important discoveries may no longer qualify for patents.

Jun 27 2016

BRIEF-Sequenom files patent infringement lawsuit in Australia

* Patent relates to detection of cell-free fetal DNA for non-invasive prenatal testing (NIPT)

Jun 07 2016

Roche tells Supreme Court no need to revisit Sequenom patent invalidation

Roche Holding AG has urged the U.S. Supreme Court not to overturn the precedents it has carefully developed over decades barring patents on natural laws and phenomena in response to a plea from Sequenom, Inc to save a patent on its prenatal DNA test from invalidation.

May 25 2016

BRIEF-Sequenom Inc reports Q1 loss per share $0.11

* Q1 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S

May 04 2016

BRIEF-Sequenom announces in-network contracts with Anthem Blue Cross, Blue Shield

* Announces in-network contracts with Anthem Blue Cross, Blue Shield plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia, Wisconsin Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 03 2016

BRIEF-Sequenom sees net cash costs about $1 mln in Q1 of 2016

* Sequenom completes consolidation of North Carolina operations

Apr 19 2016

BRIEF-Camber Capital reports 14.54% stake in Sequenom Inc

March 24 Camber Capital Management LLC Reports 14.54% Stake In Sequenom Inc As Of March 23, 2016

Mar 24 2016

BRIEF-Sequenom- enters agreements with Anthem Blue Cross, Blue Shield Health Plans

* Agreements provide in-network coverage for Sequenom laboratories nipt for both high and average-risk pregnancies to anthem's members

Mar 23 2016

Sequenom asks Supreme Court to review cancellation of prenatal test patent

Biotechnology company Sequenom Inc urged the U.S. Supreme Court on Monday to review the cancellation of its patent on a prenatal DNA test that avoids risky invasive procedures, saying a key court precedent is having the unintended effect of blocking legal protection for deserving inventions.

Mar 21 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : S&P Capital IQ Quantitative Report
Provider : Stock Traders Daily
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.